New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.

New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Abstract Text:

G Bonadonna,P Bignami,R Buzzoni,A Moliterni,P Valagussa,U Veronesi,

New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Publishing Authors By Initials

G Bonadonna,P Bignami,R Buzzoni,A Moliterni,P Valagussa,U Veronesi,

For similar proteins: receptors, cytoplasmic and nuclear: receptors, steroid: receptors, estrogen research abstracts see: proteins: receptors, cytoplasmic and nuclear: receptors, steroid: receptors, estrogen research

PUBMED ID PMID:

MEDLINE DATE:

New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 91

Page Numbers: 210-3

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1984

New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Keywords Mesh Terms:

KEYWORDS: Receptors, Estrogen

MESH TERMS: analysis

Chemical & Substance for Abstract: New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. Information

Substance Name: Methotrexate

Registry Number: 59-05-2

Grant and Affiliation Information for New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.

AFFILIATION:

Country: GERMANY, WEST

AGENCY: United States NCI

GRANT: N01-CM-07388

ACRONYM: CM

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan Related Publications

• Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.
• CMF adjuvant programs at the Milan Cancer Institute.
• Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology.
• Efficacy of hCG and GnRH for inducing ovulation in the jenny.
• Electrolytes changes in mammary secretions before foaling in jennies.
• Electron intraoperative treatment in patients with early-stage breast cancer: data update.
• Genetic diversity, structure and marker-trait associations in a collection of Italian tomato (Solanum lycopersicum L.) landraces.
• HRT opposed to low-dose tamoxifen (HOT study): rationale and design.
• Influence of age and foaling on plasma protein electrophoresis and serum amyloid A and their possible role as markers of equine neonatal septicaemia.
• Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer.
• Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution.
• Luteal function in jennies following PGF(2alpha) treatment 3 days after ovulation.
• Morphological features of the placenta at term in the Martina Franca donkey.
• Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience.
• Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro.
• New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.
• New trends in the treatment of breast cancer at the Cancer Institute of Milan.
• Paradigm changes in medical science.
• Particulate matter, oxidative stress and neurotoxicity.
• Producing a caring environment for staff: forging old paradigms.
• Regional lymph node dissection in melanoma of the limbs. Stage I. A cooperative international trial (WHO Collaborating Centers for diagnosis and treatment of melanoma).
• Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence.
• Sentinel lymph node biopsy in male patients with early breast cancer.
• The cellular and genomic response of an immortalized microglia cell line (BV2) to concentrated ambient particulate matter.
• The control of breast cancer: a look into the future.
• The effects of a nitrogen mustard derivative of phenylalanine on experimental tumours.
• Unnecessary axillary node dissections in the sentinel lymph node era.
• When Sentinel Lymph Node is Intramammary.
• Where will your attitude take you today.
• [Neoplastic transformation of cutaneous cysts; incidence, morphological aspect, pathogenesis, case reports.]